All Episodes
Pharmacology News — 433 episodes
Psychopharmacology Masterclass: Drug Classes, Mechanisms of Action, and What Every Psychologist Needs to Know for Clinical Practice and the
Retracted: The Hepatitis B Vaccine, Autism Claims, and the Challenges of Causation
Escitalopram for Kids’ Anxiety: FDA Approval or Risky Gamble? Weighing the Evidence”
Noribogaine (DMX-1001): A Neuroplastogen Breakthrough for Alcohol Use Disorder or Another Psychedelic Promise with Risks?
Rising Costs in Healthcare: The 2026 Pharmaceutical Price Increases and Their Implications
The Accidental Mind: Serendipity and the Birth of Modern Psychopharmacology part 2
The Accidental Mind: Serendipity and the Birth of Modern Psychopharmacology part 1
Curcumin: Turmeric’s Golden Promise for Blood Sugar and Mood – Evidence, Arguments For and Against
Dextromethorphan ( think cough syrup) for OCD: A Promising Glutamate-Targeted Augmentation Strategy?
Antidepressants and Suicide Prevention: Lessons from Korea’s 2002 Prescription Restrictions
Silent Slip: How Medications Are Fueling Falls in Our Elderly
The Dangerous Tetrad: Mastering the Fatal Signs of Rigidity and Fever -case study
Antidepressant Withdrawal: 50% of Long-Term Users Suffer? Shocking JAMA Study vs Real-World Reality Exposed
Metabolic Brake or Muscle Catalyst? The Pharmacokinetics of GLP-1 Muscle Loss
Ibogaine: Miracle Cure or Medical Gamble? The Truth Behind a Controversial Psychedelic
Low-Dose Methamphetamine Neuroprotection: What the Studies Actually Show
The Messy Truth About Antidepressants: Benefits, Risks, and the Limits of the Evidence
Why One ADHD Medication Hits Kids So Differently — And How Genetics Can Help
Artificial intelligence begins prescribing medications in Utah
Marijuana and emphysema
Ketamine and neurotoxicity
New study on lithium
Is low-dose quetiapine safe for insomnia?
How assessments can increase antidepressant prescriptions
Saffron being studied for insomnia
Centanafadine is a serotonin-norepinephrine-dopamine reuptake inhibitor (SNDRI) under development for ADHD.
IS THERE A DIFFERENCE BETWEEN THE INJECTABLE OR ORAL NALTREXONE AND TREATMENT
A LOOK AT BIRTH CONTROL TO DEPRESSION TO ANTIDEPRESSANTS
PRAMIPEXOLE FOR TREATMENT RESISTANT DEPRESSION
ABILIFY COULD LEAD TO GAMBLING ADDICTION
VARENICLINE POSSIBLY COULD HELP WITH ALCOHOL USE DISORDER
ANTIDEPRESSANTS DURING PREGNANCY MAY ALTER FETAL DEVELOPMENT
LEVETIRACETAM POSSIBLE ADJUNCT FOR BIPOLAR MANIA
A STUDY ON ANTIPSYCHOTICS
TOM WOLF DISCUSSES HIS OVERCOMING OF ADDICTION AND HOMELESSNESS
PSILOCYBIN USE SKYROCKETS
A POSSIBLE NEW TREATMENT FOR SCHIZOPHRENIA
ATOMOXETINE, AMPHETAMINES FOR SCHIZOPHRENIA STUDY
HOW SSRI MIGHT AFFECT HEART DEVELOPMENT
ANTIPSYCHOTICS HELPS WITH CANNABIS INDUCED PSYCHOSIS
CLOZAPINE AND HYPERSALIVATION
PIMAVANSERIN DOES IT HELP WITH SCHIZOPHRENIA AND NEGATIVE SYMPTOMS
CANNABIS AND HEART DISEASE
DR. MONCRIEFF HER NEW BOOK CHEMICALLY IMBALANCED
A BRIEF LOOK AT SOME NEW PSYCHEDELIC RESEARCH
WEIGHT LOSS DRUGS CAN HELP YOUR HEALTH IN MANY WAYS BUT THERE ARE CONCERNS
NEW ANTI-PSYCHOTIC FOR SCHIZOPHRENIA
WE LOOK AT ANTIPSYCHOTIC SIDE EFFECTS
A STUDY ON ANTIPSYCHOTICS
WE CHAT WITH DR. ARMSTRONG ABOUT PSYCHEDELICS
DR. GOMINAK DISCUSSES THE IMPORTANCE OF VITAMIN D AND SLEEP
LITHIUM COULD PREVENT HOSPITALIZATION
FDA REJECTS MDMA
CAN OZEMPIC HELP WITH ADDICTION
TOM WOLF DISCUSSES HIS OVERCOMING OF ADDICTION AND HOMELESSNESS AND WHAT TO DO ABOUT IT3
STUDY LOOKS AT MAINTENANCE OPIOID THERAPY BUPRENORPHINE
IS LITHIUM EFFECTIVE IN REDUCING SUICIDE COMPLETIONS
STUDY SHOWS OZEMPIC LINKED TO POTENTIAL VISION LOSS
EVOLUTIONARY PSYCHIATRY WITH DR.NESSE
SSRI'S STUDY SHOWS CORRELATION WITH STRESS CARDIOMYOPATHY
ESCITALOPRAM AND TREATMENT EMERGENT AFFECTIVE SWITCH
KETAMINE TABLETS SHOW PROMISE FOR TREATING SEVERE DEPRESSION
IBOGAINE AND PTSD
PSILOCYBIN VS ESCITALOPRAM WITH MAJOR DEPRESSION AND GENERALIZED ANXIETY
ADHD MEDS AND $100 MILLION FRAUD ARREST3
CELECOXIB AND POSTPARTUM DEPRESSION STUDY
FDA REJECTS MDMA FOR PTSD
STUDY ON SSRI'S AND OCD
A STUDY ON CLONIDINE AND TOURETTE SYNDROME COMORBID ADHD
ASTRA ZENECA REMOVES COVID VACCINE AFTER RARE SIDE EFFECT IS LINKED TO 80 DEATHS
L-THEANINE ADJUNCT TO SERTRALINE FOR MAJOR DEPRESSIVE DISORDER
TESTING AN OPIOID MEDICATION WITH BUILT IN PROTECTION
BUPRENORPHINE NOW CAN BE OBTAINED VIA TELEHEALTH AND MORE
WE CHATTED WITH DR. POPE ABOUT ANABOLIC STEROIDS
DR. JOSEPH DISCUSSES THE LIMITATIONS OF GENETIC STUDIES
PAXLOVID AND COVID 19 STUDY
A COMBINATION OF TWO MEDICATIONS SHOW PROMISE IN HELPING WITH ALCOHOL USE DISORDER
PRENATAL CANNABIS USE AND INCREASED RISK FOR ADHD AND AUTISM SPECTRUM DISORDER
RISK OF AUTISM AFTER PRENATAL EXPOSURE TO VALPROATE
METH RELATED CARDIO MYOPATHY
ACCIDENTAL EXPOSURE TO FENTANYL PATCHES CONTINUE TO BE DEADLY TO CHILDREN
AN INTERESTING STUDY ON PROTON PUMP INHIBITORS AND PULMONARY TB
DR. HASKINS DISCUSSES FRAUD IN THE MEDICAL FIELD1
HORMONAL CONTRACEPTION AND ADHD
WE CHAT WITH DR.PARIS AND HIS BOOK ON TRAUMA
GENETIC TESTING FOR PREDICTING ADVERSEDRUG REACTIONS DOESNT SHOW PROMISE
GABAPENTIN AND ITS USE FOR TREATING ALCOHOL USE DISORDER1
ARE BUPRENORPHINE DOSES TOO LOW
FDA TOOK LOOK AT NEW DRUG FOR SCHIZOPHRENIA
REL-1017 SHOWS EFFICACY FOR MAJOR DEPRESSIVE DISORDER IN PHASE 3
DOES EXPECTANCY BIAS PLAY A ROLE IN THE EFFICACY OF KETAMINE
VYVNANSE GENERIC APPROVED BY FDA AND LEVODOPA CARBIDOPA COMBO FOR PARKINSONS
OTC NALOXONE AND NEW NASAL SPRAY MEDICATION FOR SOCIAL ANXIETY DISORDER
TARDIVE DYSKINESIA MEDICATIONS CAN IMPROVE SOCIAL AND PHYSICAL WELL BEING
XYLAZINE PRESENCE INCREASIING IN NUMBER OF FENTANYL OVERDOSES
OPERATION ALBATROSS-SOME MEXICAN PHARMACIES SELLING FAKE ADDERALL AND MEDICATION1
CAT OWNERSHIP AND SCHIZOPHRENIA
DR. GOMINAK DISCUSSES THE IMPORTANCE OF VITAMIN D AND SLEEP
EXPERTS IN THE UK CALL FOR LESS ANTIDEPRESSANTS TO BE PRESCRIBED
ADHD MEDICATIONS AND CARDIOVASCULAR DISEASE1
ANTI OBESITY MEDICATION ASSOCIATED WITH FUNCTIONAL IMPAIRMENTS
P2P METH WHAT IS IT
US WARNS ON BUYING MEDICATION IN MEXICO
NEW STUDY ON PSILOCYBIN AND TREATMENT RESISTANT DEPRESSION
STUDY SHOWS THAT THERE IS A DANGEROUS CONNECTION BETWEEN SEROTONIN AND HEART VALVE DISEASE
TBI INTERFERES WITH IMMUNE SYSTEM CELL FUNCTIONING BUT CANCER DRUG RAPAMYCIN MIGHT HELP
CAFFEINE CAN CUT THE RISK OF PARKINSON'S DISEASE
IS RUNNING BETTER THAN ANTIDEPRESSANTS
SSRI'S MAY DAMPEN EMOTIONS
EDIBLE MUSHROOMS ENHANCES MEMORY
DOES ASPIRIN REDUCE STROKE RISK
LONG TERM USE OF ACID REFLUX DRUGS LINKED TO DEMENTIA
THE DANGER OF VAPING
NEW DRUG COULD SLOW DOWN THE PROGRESSION OF ALZHEIMERS
ONLINE TESTOSTERONE PRESCRIBING GOING ROGUE
NEW DRUG APPROVED FOR FIGHTING AGAINST INFLAMMATION
DO ORAL CONTRACEPTIVES INCREASE DEPRESSION RISK
STUDY SHOWS CBD COULD IMPACT THE FETAL BRAIN
OZEMPIC AND OTHER SEMAGLUTIDE MEDICATIONS UNDER REVIEW DUE TO CONCERNS OF TRIGGERING SUICIDAL IDEATI
A STUDY ON THE ADVERSE EVENTS ASSOCIATED WITH ESKETAMINE NASAL SPRAY
VALPROATE VS LITHUIM AND ADVERSE KIDNEY OUTCOMES
NEW STUDY LOOKED AT WHETHER OR NOT STIMULANTS USED FOR ADHD IN CHILDHOOD LEADS SUBSTANCE USE DISORDER
COMORBIDITIES LINKED TO READMISSION RISK FOR CANNABIS USE DISORDER
MEMANTINE MAY REDUCE HAIR PULLING AND SKIN PICKING
NEW STUDY WILL EXPLORE IF MUSIC CAN EFFECT HOW WE METABOLIZE DRUGS
HALLUCINATION FREE PSYCHEDELICS FOR DEPRESSION
CERTAIN MEDICATIONS CAN INCREASE YOUR RISK OF GETTING SUNBURNED
CHILDREN WITH ANXIETY ARE GETTING MORE MEDICATIONS AND LESS THERAPY
TYPE 2 DIABETES DRUG MAY REDUCE THE RISK OF DEMENTIA
TARDIVE DYSKINESIA AND ANTIPSYCHOTICS
VITAMIN D MAY BE PROTECTIVE AGAINST SOME CHILDHOOD BEHAVIORAL PROBLEMS
ANTIPSYCHOTICS AND METABOLIC SYNDROME
BIRTH CONTROL MAY BE RELATED TO POSTPARTUM DEPRESSION1
MARIJUANA HARMS DEVELOPMENT IN FIRST TRIMESTER OF PREGNANCY
OZEMPIC WEIGHTLOSS DRUG CAN IT STOP ADDICTIONS AS WELL
WHAT IS THE ZOMBIE DRUG 'XYLAZINE'
LOOKING AT OBTAINING MEDICATIONS AROUND THE WORLD1
CANNABIS USE DISORDER LINKED TO YOUNG AT HIGHEST RISK FOR SCHIZOPHRENIA
DRUG CARTELS ARE TESTING FENTANLY AMOUNTS ON DRUG ADDICTS IN TIJUANA AND MEXICALI
COPYCAT VERSIONS OF OZEMPIC WEGOVY WEIGHTLOSS DRUGS
STUDY SAYS MARIJUANA IS NOT THE SOLUTION FOR PTSD
DEPRESSION IMPROVES WITHSINGLE DOSE OF PSILOCYBIN
MDMA APPEARS TO ALTER HOW BRAIN RESPONDS TO SYMPTOM PROVOCATION IN PATIENTS WITH PTSD1
TBI INTERFERES WITH IMMUNE SYSTEM CELL FUNCTIONING BUT CANCER DRUG RAPAMYCIN MIGHT HELP1
THE DRUG FASUDIL MAY HELP TREAT CERTAIN SCHIZOPHRENIA SYMPTOMS
PHARMACIST TO BE SENTENCED FOR $11 MILLION FRAUD SCHEME
AN INTERESTING LOOK AT OZEMPIC WEIGHT LOSS MEDICATION1
SEXUAL DYSFUNCTION MAY CONTINUE EVEN AFTER SSRI'S ARE STOPPED
US WARNS ON BUYING MEDICATION IN MEXICO
COMMON CLEANING CHEMICAL COULD CAUSE PARKINSONS1
MARIJUANA CAN RAISE THE RISK OF CORONARY ARTERY DISEASE
PSYCHEDELICS MAY HELP PEOPLE REINVENT THEMSELVES
EXERCISE MORE EFFECTIVE THAN MEDICINES OR COUNSELING IN MANAGING MENTAL HEALTH
EDIBLE MUSHROOMS MAY CAUSE NERVE GROWTH AND ENHANCE MEMORY
PSYCHEDILICS MAY ALLEVIATE MENTAL ILLNESS ACCORDING TO STUDY
MDMA AND PSILOCYBIN APPROVED FOR THE FIRST TIME IN AUSTRALIA
VAPING AND THE IMMUNE SYSTEM
A NEW ANTIDEPRESSANT DRUG MIGHT BE HELPFUL IN TREATING ALCOHOL USE DISORDER1
STUDY SHOWS THAT THERE IS A DANGEROUS CONNECTION BETWEEN SEROTONIN AND HEART VALVE DISEASE
20% OF AMERICANS USE SLEEP MEDICATION 1
SSRI'S MAY DAMPEN EMOTIONS
MEDICATIONS WITH LARGER ADVERTISING BUDGETS ARE TYPICALLY LOW IN THERAPEUTIC VALUE
NEW STUDY LOOKING AT CANNABIS , THE ORAL MICROBIOME AND ITS IMPACT ON THE BRAIN
OLDER ADULTS ENDING UP IN THE ER BECAUSE OF CANNABIS USE IS UP AN ALARMING RATE2
FIRST OF ITS KIND PSYCHEDELIC TRIALS FOR TREATING OPIOID AND METH USE DISORDERS
A THIRD OF PEOPLE USE MARIJUANA FOR CHRONIC PAIN
GABAPENTIN IS AN EMERGING THREAT IN ADDICTION
KETAMINE CAN INCREASE BRAIN NOISE
DRUGS FOR EPILEPSY MAY INCREASE RISK OF PARKINSONS
PSYCHOPATHS BRAINS DONT RESPOND TO DRUG CUES THE SAME AS NON-PSYCHPATHSO1
ANTIDEPRESSANT USE DURING PREGNANCY MAY ALTER NEUROBIOLOGY OF BABIES BRAIN
P2P METH WHAT IS IT
PSILOCYBIN INCREASES MINDFULNESS
HIGHER LEVELS OF VITAMIN D IN THE BRAIN IS ASSOCIATED WITH BETTER COGNITIVE FUNCTION
KETAMINE MIGHT HELP WITH TREATING ANOREXIA
LSD MICRODOSING MIGHT HELP WITH REWARD RESPONSE FOR INDIVIDUALS WITH DEPRESSION
SHOULD YOU AVOID ALCOHOL WHILE TAKING FLAGYL
NEW STUDY LOOKS AT RITALIN AND DOPAMINE AND THE RELATIONSHIP1
STUDY LOOKS AT THE CORRELATION BETWEEN AFIB AND OPIOIDS, CANNABIS, METH, AND COCAINE
PSILOCYBIN SHOWS GENDER SPECIFIC DIFFERENCES IN AMYGDALA REACTIVITY1
RITALIN'S EFFECTS ON DOPAMINE IN THE BRAIN1
THE EFFECT OF PRESCRIBED STEROIDS ON THE BRAIN
WHATS RAINBOW FENTANYL
MARIJUANA AND HALLUCINOGEN USE AMONG YOUNG ADULTS REACHES ALL TIME HIGH
STUDY SHOWS CBD MIGHT HELP REDUCE ANXIETY IN YOUNG PEOPLE1
NEW STUDY ON SEROTONIN SHAKES UP THE PSYCHIATRY AND PHARMACOLOGY WORLD1
TARDIVE DYSKINESIA AND ANTIPSYCHOTICS
ANTIHISTAMINES POSSIBLY LINKED TO OBESITY
A NEW STUDY ON ANTIDEPRESSANTS AND PREGNANCY
A DOUBLE BLIND PLACEBO STUDY OF BREXPIPRAZOLE FOR THE TREATMENT OF BORDERLINE HAS ODD RESULTS
DR. GOMINAK DISCUSSES THE IMPORTANCE OF VITAMIN D AND SLEEP2
NEW STUDY SHOWS CANNABIS MAY NOW CAUSE ONE IN FOUR NEW CASES OF SCHIZOPHRENIA
REPURPOSING OF TWO OLD DRUGS-ASPIRIN AND THALIDOMIDE
P2P METH WHAT IS IT
HOW DO MEDICATIONS TRAVEL IN THE BODY
THE PROS AND CONS OF USING STIMULANTS WITH BUPRENORPHINE FOR OPIOID ADDICTION CLIENTS
PHARMACIST CONVICTED OF DISTRIBUTING OVER 750,000 OF CONTROLLED SUBSTANCES UNLAWFULLY2
REVIEW OF BENZTROPINE
METH AND FACE SORES PLUS MUCH MORE
BUPRENORPHINE AND SUBOXONE AND TOOTH DECAY
FREQUENT MARIJUANA SMOKING LINKED TO HIGHER RISK OF HEART DISEASE
STUDY SHOWS HOW PSILOCYBIN MIGHT HELP PEOPLE WITH SEVERE DEPRESSION
AANOTHER PFIZER BLOOD PRESSURE MEDICATION RECALLED
DRUG USED TO TREAT ALCOHOLISM SHOWS PROMISE FOR ANXIETY
IBOGAINE MAY HELP WITH BLOCKING REWARDING EFFECTS OF ALCOHOL
CANNABIS USE DISORDER AFFECTS COGNITION
AMPHETAMINES LINKED TO A 5 FOLD HEIGHTENED RISk OF PSYCHOSIS
CBD AND PSYCHIATRIC DISORDERS- WE LOOK AT THREE NEW STUDIES
FDA APPROVES QUVIVIQ FOR INSOMNIA
NEW ANTIPSYCHOTIC APPROVED FOR SCHIZOPHRENIA
ANTIPSYCHOTIC LYBALVI ASSOCIATED WITH LESS WEIGHT GAIN THAN OLANZAPINE
PSYCHEDELIC MDMA SHOWS PROMISE IN TREATING PTSD NEW STUDY SHOWS
CAPLYTA APPROVED FOR BOTH BIPOLAR I AND II
ANTIDEPRESSANTS USE IN EARLY PREGNANCY MAY BE LINKED TO BIRTH DEFECTS
EFFECTS OF KETAMINE ON NEUROCOGNITION AT 24 HOURS IN DEPRESSED PATIENTS WITH SUICIDAL IDEATION
STUDY FINDS PEOPLE WHO USE ILLICIT AMPHETAMINES ARE A 5X HIGHER RISK OF DEVELOPING PSYCHOSIS
NEW LSD FOUND NO EVIDENCE THAT MICRODOSING IMPROVES MOOD
A STUDY LOOKS AT VETERANS AND CANNABIS USE DISORDER
WE DISCUSS TRAZADONE
VIAGRA MIGHT HELP PREVENT ALZHEIMERS
BUPRENORPHINE MAY CURB OPIOID RESPIRATORY DEPRESSION
OFF LABEL ANTIPSYCHOTICS MAY BE ASSOCIATED WITH CARDIOMETABOLIC MORTALITY
SEROTONIN MEDIATED ANXIETY
CALCINEURIN INHIBITOR INDUCED PSYCHOSIS
TOPIRAMATE AND COCAINE USE DISORDER
TARDIVE DYSKINESIA AND ANTIPSYCHOTICS
DEA BUSTS DRUG RING TIED TO SINALOA CARTEL IN DENVER, CO
NUTRITION AND MENTAL HEALTH
CANNABIS FOR PSYCHIATRIC DISORDERS
USING CANNABIS ALONGSIDE OTHER DRUGS MAY BE HARMFUL
ANTIDEPRESSANTS USE IN EARLY PREGNANCY MAY BE LINKED TO BIRTH DEFECTS
NEW SPHERICAL NUCLEIC ACID DRUG FOR BRAIN TUMORS
WOMEN WHO VAPED ARE MORE LIKELY TO HAVE LOW BIRTH WEIGHT BABIES
CHRONIC MARUJUANA USE LOWERS EMOTIONAL INTELLIGENCE ACCORDING TO NEW STUDY
NEW STUDY FLUVOXAMINE AMONG PATIENTS WITH COVID-19
THE PLACEBO EFFECT AND TREATMENT RESISTANT DEPRESSION
WE DISCUSS THE SIDE EFFECTS OF HEROIN
DR. HELLERSTEIN DISCUSSES THE LATEST RESEARCH ON PSILOCYBIN AND TREATMENT RESISTANT DEPRESSION
CAN CAFFEINE HELP WITH ADHD
GENETIC LINK MAY TIE CANNABIS USE DISORDER TO SEVERE COVID
FDA APPROVES FIRST TWICE YEARLY ANTIPSYCHOTIC FOR SCHIZOPHRENIA
CONCERNS OF MICRODOSING WITH PSILOCYBIN
DRUG CARTELS INCREASE METHAMPHETAMINE AND ONLINE SALES IN US AND EUROPE4
THC AND LIPID COMBO HELPS REDUCE TOURETTE'S SYMPTOMS
SIDE EFFECT BURDEN PREDICTS RESPONSE TO ANTIDEPRESSANT
BREXANOLONE SHIFTS NEURAL RHYTHMS IN BASOLATERAL AMYGDALA
SMOKING MARIJUANA CORRELATED TO BREAKTHROUGH COVID CASES
EFFECTIVENESS OF REAL WORLD STUDIES OF ANTIPSYCHOTICS IN SCHIZOPRENIA COMPARED TO RANDOMIZED CONTROL
WHAT ARE THE EFFECTS OF COCAINE ON THE BRAIN AND THE BODY
COUNTERFEIT PILLS ACTUALLY FENTANYL LEADING TO RISE IN DEATHS1
STUDY LOOKS AT ANTIPSYCHOTICS AND THEIR EFFECTS ON COGNITION
CALIFORNIA LOOKING TO LEGALIZE PSYCHEDELICS SUCH AS LSD AND ECSTASY1
HOW YOUR STOMACH INFLUENCES THE EFFECTS OF MEDICATION
THE PSYCHOLOGICAL AND PHYSIOLOGICAL DAMAGE CAUSED BY METH
CANNABIS USE COULD BE TIED TO RISK OF SUICIDAL THOUGHTS
ZURANOLONE MIGHT HELP WITH POSTPARTUM DEPRESSION
VRAYLAR APPROVED FOR BIPOLAR DISORDER
NARCAN NOW AVAILABLE IN NASAL SPRAY FORM
FDA ADDS BOXED WARNINGS FOR CERTAIN INSOMNIA DRUGS INCLUDING AMBIEN
NEW STUDIES ON PSYCHEDILICS SHOW PROMISE BUT QUESTIONS REMAIN
FDA WILL REVIEW BRIXADI BUPRENORPHINE INJECTION FOR OPIOID USE DISORDER
TWO NEW MEDICATIONS GIVEN BREAKTHROUGH DESIGNATION FOR TREATING ALZHEIMER'S
MDMA ASSISTED CBT MAY HELP COUPLES OVERCOME PTSD
WOMEN WHO VAPED ARE MORE LIKELY TO HAVE LOW BIRTH WEIGHT BABIES
PSILOCYBIN MIGHT ALTER HOW THE BRAIN INTEGRATES TOUCH
COFFEE DRINKING MAY BE A FACTOR OF DEMENTIA
PIMAVANSERIN CUTS DOWN DEMENTIA RELATED PSYCHOSIS RELAPSE
HIGH POTENCY MARIJUANA LINKED TO PSYCHOSIS AND MYSTERIOUS VOMITING ILLNESS
PROFESSOR NUTT DISCUSSES MDMA AND ITS ROLE WITH PTSD
A LOOK AT THE PREVALENCE OF THE USE OF KRATOM
FDA APPROVES ADHANSIA FOR ADULTS WITH ADHD
SLOW RELEASE MORPHINE MAY HELP WITH OPIOID USE DISORDER
A LOOK AT ANTIPSYCHOTIC MEDICATIONS
ZURANOLONE WINS FOR QUICK DEPRESSION RELIEF
INVESTIGATIONAL ALZHEIMERS DRUG SHOWS EFFECTS IN REDUCING AMYLOID
THE OXY BANDITS - PHARMACY ROBBERIES
WE DISCUSS THE BENEFTIS OF PHARMACOGENETIC TESTING
EZOGABINE SHOWS PROMISE AS AN ANTIDEPRESSANT
ANTIPSYCHOTICS STIMULATE PANCREAS TO MAKE MORE HORMONES WHICH COULD INCREASE RISK FOR DIABETES
NEW FDA APPROVED DRUG FOR ALZHEIMERS IS MARRED IN CONTROVERSY
CANNIBINOIDS MAY HELP INCREASING APPETITE FOR PEOPLE WITH DEMENTIA
STUDY SHOWS PROMISE WITH MDMA AS AN ADJUNCTIVE TO THERAPY REDUCING PTSD SYMPTOMS
METH INDUCED PSYCHOSIS
CARIPRAZINE MAY INTERFERE WITH FETAL BRAIN DEVELOPMENT
DOES ALCOHOL WITHDRAWAL SEVERITY INFLUENCE THE EFFICACY OF PRAZOSIN
PHASE TRIAL FOR TRORILUZOLE FOR OCD
AZSTARYS APPROVED FOR TREATMENT FOR ADHD
DARIDOREXANT SUBMITS FOR NEW DRUG APPLICATION FOR TREATING INSOMNIA
DR. GILMAN DISCUSSES THE DANGERS OF MISLEADING CLAIMS AND SALES OF CBD AND MARIJUANA
FDA WARNS COMPANIES ABOUT ILLEGAL SALES OF CBD PRODUCTS
LAMICTAL MAY INCREASE ARRHYTHMIAS
FDA TO REVIEW ATOGEPANT FOR MIGRAINE PREVENTION
FDA APPROVES SNRI QELBREE FOR ADHD
WE DISCUSS SEVERAL STUDIES ON MARIJUANA USE DURING PREGNANCY AND ITS EFFECTS ON THE CHILD
ANTIDEPRESSANTS USE IN EARLY PREGNANCY MAY BE LINKED TO BIRTH DEFECTS
WHICH MEDICATIONS ARE MOST TOXIC TO THE LIVER
PSILOCYBIN IMPROVES OVERALL SYMPTOMS OF DEPRESSION
CLOZAPINE FOUND MOST EFFECTIVE IN PATIENTS WITH SCHIZOPHRENIA AND CONDUCT DISORDER
FDA APPROVES NEW DUAL ACTION STIMULANT MEDICATION FOR ADHD
CAN ESTROGREN HELP WITH MS SYMPTOMS
SOME ANTIDEPRESSANTS CAN INCREASE THE RISK OF DEMENTIA
VALPROATE IS CONTRAINDICATED FOR THOSE WITH ADVANCED CIRRHOSIS
PRAZOSIN FOR PTSD SLEEP DISTURBANCES DOES IT REALLY WORK
KETAMINE MAY HELP WITH MAJOR DEPRESSION
NALOXONE CASES THAT MIGHT BE LINKED TO PULMONARY EDEMA
DR. HELLERSTEIN DISCUSSES THE LATEST RESEARCH ON PSILOCYBIN AND TREATMENT RESISTANT DEPRESSION
KETAMINE NORMALIZES HYPERACTIVITY IN KEY BRAIN REGION OF PATIENTS WITH MAJOR DEPRESSION
SOME PATIENTS WITH DEPRESSION MAY BENEFIT FROM ADDING ON THIS ANTIBIOTIC
THE USE OF BUPRENORPHINE AND NALOXONE
DO ANTIDEPRESSANTS INCREASE DEMENTIA
LARGE META ANALYSIS ON BETA BLOCKERS AND DEPRESSION
THC FROM MARIJUANA CAN STAY IN BREAST MILK FOR SIX WEEKS
MARIJUANA SHOWS LINK TO SUICIDE AMONG YOUTH
KETAMINE INFUSIONS LINKED TO FAST RELIEF OF PTSD
PHARMACOLOGIC TREATMENT FOR OPIOID USE DISORDER ALSO REDUCES RISK FOR ALCOHOL RELATED HOSPITALIZATIO
MARIJUANA AND CANNABINOID HYPEREMESIS SYNDROME
NEW STUDY SHOWS HOW ANTIPSYCHOTICS CAN CAUSE WEIGHT GAIN
MEDICATIONIN CONJUNCTION WITH CBT SHOWED MORE EFFICACY FOR PEOPLE WITH INSOMNIA
A LOOK AT PRENATAL CANNABIS USE AND RISK FOR PSYCHOPATHOLOGY
PHENOBARBITAL AND CLONIDINE AS SECONDARY MEDICATIONS FOR NEONATAL OPIOD WITHDRAWAL SYNDROME
NEFLAMAPIMOD MAY IMPROVE COGNITION IN DEMENTIA WITH LEWY BODIES
BENADRYL CHALLENGE COULD BE DEADLY WARNS FDA
LANGUAGE PROBLEMS WITH SOME ANTIPSYCHOTICS IN PATIENTS WITH SCHIZOPHRENIA
AUGMENTING WITH SECOND GENERATION ANTIPSYCHOTIC INCREASES RISK OF DEATH FOR SOME PATIENTS
FETAL EXPOSURE TO ALCOHOL, CANNABIS CAN HAVE LONG TERM CONSEQUENCES 1
A LOOK AT PHARMACOTHERAPY AND BORDERLINE PERSONALITY DISORDER
IT APPEARS GOLDENSEAL MAY HAVE AN EFFECT ON DIABETES MEDICATION
THE LATEST ON PSYCHEDELIC RESEARCH
THE VARIANCES OF OPIOD RELATED HARM BETWEEN RACES
VARIOUS INHALATION DEVICES FOR MARIJUANA
NICOTINE VAPING TAPERS OFF AMONG US TEENS
THE BENEFITS OF USING 2ND GENERATION ANTIPSYCHOTIC MEDICATION AS EARLY AS POSSIBLE
TREATMENT FACTORS TO CONSIDER FOR ADHD
WHAT ARE CLASSIC PSYCHEDELICS
EXPOSURE TO VALPROATE IN UTERO MAY INCREASE RISK OF AUTISM AND ADHD
CERTAIN PARKINSONS DRUGS CAN LEAD TO GAMBLING ADDICTION AND HYPERSEXUALITY
PARACETAMOL DURING PREGNANCY AND AFFECTS ON CHILD DEVELOPMENT
ANTIDEPRESSANTS AND BIRTH DEFECTS STUDIED
ARE LONG ACTING INJECTABLE ANTIPSYCHOTICS HELPFUL FOR PEOPLE WITH SCHIZOPRENIA
TOMATOES OFFER A POSSIBLE SOURCE OF PARKINSON'S DISEASE DRUG
RILUZOLE MAY REDUCE HYPERAROUSAL FOR PTSD PATIENTS
FLUXOVAMINE TRIAL PROVIDES HOPE IN REDUCING COVID 19 INFECTIONS
A LOOK AT THE MECHANISM OF ACTION AND MORE OF NAXOLONE
ANTI-DIARRHEA DRUG DRIVES CANCER TO CELL DEATH
VIOXX PHARMA SCANDAL1
NEW RX STRATEGY COULD HELP IN RECOVERING FROM STROKES
BREAKTHROUGH MEDICINE DEXAMETHASONE AND COVID
KETAMINE FOR DEPRESSION
MEXICAN CARTELS AND THE NETHERLANDS2
THE SCIENCE OF OXYTOCIN AND BONDING
Can aspirin help with Covid19
New Technology passes cannabis to brain through blood-brain barrier
Bumetanide and Autism Spectrum Disorder
Some Hypertension medications may protect against depression
Antidepressant use in early pregnancy may be linked to birth defects
Lithium and cognitive impairment and sexual dysfunction
FDA approves Phesgo for breast cancer treatment
SSRI and SSNI for children with anxiety
new antibody shows signficant promise for alzheimers patients
phase 3 data positive for insomnia drug
Esketamine and major depressive disorder
The effects of clozapine and the risk of suicide for patients with Schizophrenia
Sertraline can it reduce irritability for depressed patients
possible new strategy for treating Duchenne muscular dystrophy
how ypur gut influences medications
Smartwatch tracks medication levels to personalize treatments
Medication might reduce agitation in schizophrenia and bipolar disorder
Pimavanserin being considered for psychosis related dementia
Xywav approved for narcolepsy
possible medication for sleep eating
DEA takes Epidiolex (cannabidiol) off of Schedule V
DEA expands production quota for these particular drugs
ALARMING RISE OF XANAX SINCE COVID CRISIS
Psilocybin and depression
Lithium in water to reduce suicide and criminal behavior
Jake the Snake Roberts discusses his battle with addiction1
combination drug shows great promise for patients with migraines
new medication shows promise for Adult ADHD
pimavanserin may improve sexual function for patients with major depression disorder
Schizophrenia, clozapine and covid 19 complications
use of anti psychotics for bipolar disorder is on the rise but why
cannabis withdrawal syndrome
new trial studies for depression Medication for parkinson patients
Teen polydrug abuse
Do antidepressants increase the chance of dementia
Xanax and some precautions such as grapefruit and the effect of tobacco
the negative effects of combining xanax and amphetamines
Can taking valium or Xanax increase the risk of a ectopic pregnancy
Two medications for autism spectrum disorder are compared
Does marijuana improve your sex life1
New genetic discoveries concerning schizophrenia, and update on drug smuggling
Studies on Lithium for adolescent and children with Bipolar disorder
The importance of medication compliance
potential dangers of mixing supplements and medications
lethal drug combinations
Can the SSRI Citalopram make you more moral?
New Drug trio that can reduce symptoms and duration of Coronavirus
Coronavirus heroin?
The growing problem of marijuana concentrates and teens
Tripping on a placebo? Psychedelic drugs and placebo effect
What is spice?
What to do with a treatment resistant OCD client
SSRI's or antidepressants and sexual side effects
We take a look at cocaine
Can CBD help with heroin abstinence and craving
grapefruit and medication interactions
A look at regional differences in drug overdoses
What is krokodil or Russian Magic
association with antipsychotics and weight gain
Acetaminophen implicated again in autism and ADHD
Can ketamine be used to help with depression?
Is Cinnamon completely harmless?
Is Chloroquine the magic pill against Coronavirus?
Can smoking or vaping make you more susceptible to the coronavirus?
Is SSRi use during pregnancy associated with Autism Spectrum Disorder?
Ocytocin found to increase empathy among patients with borderline personality disorder
Caplyta a new drug to help individuals with schizophrenia
What is the stimulant Khat?
Does Vaping change your DNA like cigarettes?
What medical benefits does marijuana have We chat with Dr. Hutchison
What do the different colors of meth mean?
The use of Ketamine for Treatment resistant depression
Do magic mushrooms (Psilocybin) help with focused attention?
We discuss alcohol addiction with Dr. Koob of the National Institute on Alcohol Abuse
Switerzland fights heroin with heroin
What is the street drug known as LEAN or Purple Drank?
A look at Marijuana and its effects on PTSD symptoms
is marijuana good for depression?
We discuss the dangers of meth
We discuss the street drug Flakka, what is it?
Can magic mushrooms help with depression? Doctors think so
What is the difference between dependence and addiction
What is Addiction?